Navigation Links
Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine
Date:6/19/2013

s announcement, the words "anticipate", "believe", "estimate", "expect", "expectation", "goal", "should", "would", "project", "plan", "predict", "intend", "target" and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to us and are subject to a number of risks, uncertainties and other factors that could cause our actual results, performance, expected liquidity or achievements to differ materially from those projected in, or implied by, these forward-looking statements. Factors that may cause such a difference include, without limitation, our need for substantial additional financing and the availability and terms of any such financing, the safety and/or efficacy results of clinical trials of our product candidates, our failure to obtain regulatory approvals or comply with ongoing governmental regulation, our ability to commercialize, manufacture and achieve market acceptance of any of our product candidates, for which we rely heavily on collaboration with third parties, and our ability to protect and enforce our intellectual property rights and to operate without infringing upon the proprietary rights of third parties. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, performance or achievements and no assurance can be given that the actual results will be consistent with these forward-looking statements. For more information about the risks and uncertainties that may affect our results, please see the Risk Factors section of our filings with the Securities and Exchange Commission, including our transition report on Form 10-K for the six month period ended December 31, 2012 and quarterly reports on Form 10-Q. We do not intend to update any of the forward-looking statements after the date of this announcement to conform these statements to actual results, to changes in managem
'/>"/>
SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine
2. Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
3. Ibrutinib Phase 2 Data: Analyses Show Efficacy with Ibrutinib Monotherapy in Patients with Relapsed or Refractory Mantle Cell or Diffuse Large B-cell Lymphoma
4. Ibrutinib Expanded Access Program Open to Eligible U.S. Patients with Relapsed or Refractory Mantle Cell Lymphoma
5. Phase II Ibrutinib Monotherapy Study Shows CLL Patients Achieved Rapid and Sustainable Disease Control Irrespective of Age or High Risk Prognostic Factor
6. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
7. Ibrutinib Receives Two Oncology Breakthrough Therapy Designations from U.S. Food and Drug Administration
8. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
9. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
10. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
11. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... 12, 2014 The report ... (Alcoholic, CSD, Sports & Energy Drinks, Others), Food ... & Seafood)], by Material (Aluminum & Steel) - ... and segments the Food & Beverage Metal Cans ... in terms of volumes and values. The application ...
(Date:9/12/2014)... /PRNewswire-iReach/ -- 9 th Annual FDA Inspections Summit ... Bethesda, MD Early Bird Registration discount ends ... Photo - http://photos.prnewswire.com/prnh/20140912/145652 What ... to get a glimpse into the inner workings of ... Come to Washington ...
(Date:9/12/2014)... 2014 Research and Markets ... Medical Technologies Market 2014-2018" report to their ... collective term for software solutions, medical devices, imaging ... The Global Medical Technologies market covers active implantable ... vitro diagnostics technology, dental technology, electromechanical medical technology, ...
Breaking Medicine Technology:Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 2Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 3Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 4FDAnews Announces: Early Bird Registration Discount Ends Sept.19 for 9th Annual Inspections Summit, Oct. 22-24, 2014 2FDAnews Announces: Early Bird Registration Discount Ends Sept.19 for 9th Annual Inspections Summit, Oct. 22-24, 2014 3Global Medical Technologies Market 2014-2018: Key Vendors are GE, Johnson & Johnson, Medtronic, Roche and Siemens 2Global Medical Technologies Market 2014-2018: Key Vendors are GE, Johnson & Johnson, Medtronic, Roche and Siemens 3
... (Nasdaq: ARAY ), the premier radiation ... Especialidad in Monterrey, Mexico has starting treating patients with ... is the first center in Mexico now offering patients ... anywhere in the body. The CyberKnife System ...
... Jan. 17, 2012  Ventana Medical Systems, Inc. (Ventana), ... that it has entered into a strategic collaboration ... a molecular companion diagnostic test intended to identify ... Bayer antibody-drug conjugate (ADC). Ventana,s diagnostic immunohistochemistry platform ...
Cached Medicine Technology:First CyberKnife Robotic Radiosurgery System Goes Live in Mexico 2First CyberKnife Robotic Radiosurgery System Goes Live in Mexico 3First CyberKnife Robotic Radiosurgery System Goes Live in Mexico 4Ventana Medical Systems, Inc. to Collaborate with Bayer on Companion Diagnostic Test for New Biological Cancer Therapy 2Ventana Medical Systems, Inc. to Collaborate with Bayer on Companion Diagnostic Test for New Biological Cancer Therapy 3
(Date:9/15/2014)... San Diego, CA (PRWEB) September 15, 2014 ... website daily regarding all the latest information from the ... Following a previous announcement from the FDA, the Agency ... Labs (aka NuVision Pharmacy) the immediate recall ... on the market that are not expired due to ...
(Date:9/15/2014)... Lauderdale, FL (PRWEB) September 15, 2014 (PRWEB) September 15, ... and what’s not; what the startup business requirements are ... market the new business. , Speakers include industry professionals, ... Harborside Health Center in Oakland,CA and cannabis business ... CO , who are already successfully running legal marijuana ...
(Date:9/15/2014)... Recently, Top10BestSEOHosting.com has compared many professional ... http://www.greengeeks.com/cgi-bin/affiliates/clickthru.cgi?id=seohosts ), IX Web Hosting and GoDaddy are ... “These companies have outperformed other competitors in hosting ... we call them the Best VPS Hosting supplier. ... best web hosting to enjoy the power of ...
(Date:9/14/2014)... (PRWEB) September 15, 2014 Skin becomes dryer ... like sun damage and not moisturizing properly. However, there are ... has been cared for. , Two main reasons this occurs: ... of hyaluronic acid in the skin , During the aging ... of these are responsible for important moisture retention and radiance ...
(Date:9/14/2014)... St. Louis, MO (PRWEB) September 14, 2014 ... events can now use the Quotes Pros website to ... portal that was constructed this year at http://quotespros.com/life-insurance.html ... , The insurance company partners that are preparing ... this year are located in most U.S. states. As ...
Breaking Medicine News(10 mins):Health News:FDA Requests Recall of Sterile Drug Products by Downing Labs (aka NuVision Pharmacy): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:How to Start And Run a Successful Legal Marijuana Business 2Health News:2 Reasons Skin Becomes Dryer with Age and What To Do About It, From Sublime Beauty® 2Health News:2 Reasons Skin Becomes Dryer with Age and What To Do About It, From Sublime Beauty® 3Health News:Quotes for Life Insurance Now Offered at New Consumer Portal Online 2
... MD, former chief of pediatrics at Women & Infants Hospital ... Brown University, was recently inducted into the Legends of Neonatology ... Oh was one of two physicians inducted this year for ... Later this month, Dr. Oh will also receive another prestigious ...
... Baltimore, MD A study released today by the ... Bloomberg School of Public Health has identified the most ... could offer the best hope yet for scaling up ... taking aim at the country,s precipitous number of child ...
... 12 (HealthDay News) -- A toxic component of a plant ... failure and upper urinary tract cancer, researchers warn. Aristolochic ... used for centuries and still are used in many countries. ... cancer in Taiwan concluded that aristolochic acid is a primary ...
... THURSDAY, April 12 (HealthDay News) -- Even though a child,s ... finds that the marriages and partnerships of parents of kids ... study debunks "a persistent myth that childhood cancer will have ... simply not true," said Anne Kazak, professor of pediatrics at ...
... , WEDNESDAY, April 11 (HealthDay News) -- The U.S. ... producers, drug companies and veterinarians to help limit the ... of mixing antibiotics in animal feed to make livestock, ... to disease has been criticized for years in many ...
... A first of its kind study conducted by ... (IPC) found that one fall requiring first responder emergency ... hours at Boston Logan International Airport, with 37 percent ... study, which was done at the request of the ...
Cached Medicine News:Health News:Dr. William Oh named 2012 Legend of Neonatology 2Health News:New study identifies promising, achievable solutions to Nigeria's childhood mortality crisis 2Health News:New study identifies promising, achievable solutions to Nigeria's childhood mortality crisis 3Health News:Herbal Remedy Ingredient Tied to Cancer, Kidney Failure 2Health News:Parents of Kids With Cancer No More Likely to Break Up 2Health News:FDA Seeks to Limit Antibiotics in Animal Feed 2Health News:FDA Seeks to Limit Antibiotics in Animal Feed 3Health News:BMC study shows diverting passengers to elevators could help reduce falls at Logan Airport 2
Provides reliable information on the most commonly prescribed drugs, their side effects, interactions and cost of therapy....
Very concise book answering the question: "I've got a diagnosis, which drugs do I use?". All 15 chapters written by highly skilled US specialists...
Make better prescribing decisions with this drug interaction analyzer containing over 3,000 brand names with generic equivalents....
Davis's Drug Guide for Nurses - now with over 760 Integrated Calculators - combines the most comprehensive, up-to-date and practical drug resource with built in drug dosing calculation tools for most...
Medicine Products: